Resource Library

Resource Library

Filter Resources

Area of Interest

Resource Type

      Publication

      Efficacy of anti-PD1/PD-L1 immunotherapy in non–small cell lung cancer is dependent upon Immunoscore IC CD8 and PD-L1 status

      Poster

      SITC 2022: Brightplex® TCE and Brightplex® MDSC assays in combination improve NSCLC patient stratification under anti-PD1/L1 immunotherapy in the PIONeeR project

      Poster

      SITC 2022: Assessment of the spatial distribution and cell-to-cell interactions in the tumor micro-environment, within and between serial slides stained with Brightplex®, a sequential chromogenic multiplex assay

      Poster

      Comprehensive biomarkers analysis to explain resistances to PD1/L1 ICIs: The Precision Immuno-Oncology for advanced Non-Small CEll Lung CancER (PIONeeR) trial.

      Poster

      Assessment of the spatial distribution of CD4+T cells subpopulations in the tumor microenvironment by Brightplex®, a sequential chromogenic multiplex assay

      Poster

      Assessment of the spatial distribution of B cells subpopulations in the tumor microenvironment and tertiary lymphoid structures by Brightplex®, a sequential chromogenic multiplex assay

      Poster

      Spatial distribution of infiltrating T lymphocytes with Immunoscore® CR T Cells Exhaustion test helps stratification of NSCLC patients treated with PD1 / PDL1 inhibitors in the PIONeeR project

      Poster

      LTX-315, a first in class oncolytic peptide reshapes the tumor microenvironment inducing a local and systemic effect in metastatic tumors: Results from an ongoing study

      Poster

      A multiplex immunohistochemistry assay for immune cells profiling on whole FFPE tumor tissue sections

      Poster

      LTX-315, a first in class oncolytic peptide, reshapes the tumor microenvironment in the patients with advanced metastatic tumors: Results from an ongoing study

    Contact our team to discuss your project